SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-02-012962
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
8
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2074399z10-k.txt 10-K 401044
3 EXHIBIT 10.28 a2074399zex-10_28.txt EX-10.28 43091
4 EXHIBIT 10.29 a2074399zex-10_29.txt EX-10.29 43021
5 EXHIBIT 10.30 a2074399zex-10_30.txt EX-10.30 18617
6 EXHIBIT 21 a2074399zex-21.txt EX-21 483
7 EXHIBIT 23.1 a2074399zex-23_1.txt EX-23.1 640
8 EXHIBIT 23.2 a2074399zex-23_2.txt EX-23.2 805
9 EXHIBIT 23.3 a2074399zex-23_3.txt EX-23.3 802
  Complete submission text file 0000912057-02-012962.txt   510697
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19319 | Film No.: 02596971
SIC: 2834 Pharmaceutical Preparations